Top news of the week: 18.10.2023.
Dow Jones Drops After Strong Retail Sales; Tesla Stock Slides On Recall; Nvidia Dives On AI Chip Ban
Key earnings movers are Bank of America, Goldman Sachs and Johnson & Johnson.
What I've been reading, October 2023: The stirrup in Europe, 19th-century art deco, and more
A ~monthly feature. Last month was busy for me with a lot of travel and a lot of focus on The Roots of Progress as a nonprofit organization, so I hav…
The stock market is getting Ozempic'ed
The collective shedding of billions of pounds thanks to GLP-1 drugs is poised reshuffle trillions of dollars in the stock market and economy.
BioNTech’s stock sinks after disclosing expected charge of up to nearly $1 billion resulting from Pfizer’s write offs of COVID products
Shares of BioNTech SE sank 6.1% toward a 2 1/2-year low in premarket trading Monday, after the Germany-based biotechnology company disclosed that it...
The vitamin D receptor agonist EB1089 can exert its antiviral activity independently of the vitamin D receptor
Vitamin D has been shown to have antiviral activity in a number of different systems. However, few studies have investigated whether the antiviral activity is exerted through the vitamin D ...
Near-4,000% surge catapults one tiny biotech firm to record week
Shares of Tempest have come off that high in the two latest trading sessions as investor enthusiasm moderated and a broader market selloff in risky assets batters the high-risk ...
3 Nasdaq Biotechs With New 52-Week Highs
Biotech stocks are having a bad year with the XBI trending downward for months now, but at least 3 Nasdaq-traded biotechnology companies are now hitting 52-week highs:...
Why a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
Results from a Roche-Run liver cancer trial involving Tempest Therapeutics' experimental therapy sent its shares surging.